SageView Advisory Group’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Buy
16,533
+2,105
+15% +$381K 0.08% 139
2026
Q1
$2.12M Sell
14,428
-2,527
-15% -$411K 0.08% 131
2025
Q4
$3.3M Sell
16,955
-1,204
-7% -$287K 0.11% 110
2025
Q3
$5.11M Sell
18,159
-1,063
-6% -$271K 0.18% 72
2025
Q2
$4.76M Buy
19,222
+3,939
+26% +$636K 0.18% 62
2025
Q1
$2.14M Buy
15,283
+585
+4% +$95.2K 0.09% 118
2024
Q4
$2.45M Buy
14,698
+4,365
+42% +$775K 0.11% 108
2024
Q3
$1.76M Sell
10,333
-1,113
-10% -$161K 0.09% 126
2024
Q2
$1.62M Buy
+11,446
New +$1.42M 0.08% 149
2024
Q1
Sell
-12,812
Closed -$1.46M 706
2023
Q4
$1.46M Buy
12,812
+1,975
+18% +$216K 0.06% 197
2023
Q3
$1.15M Buy
10,837
+5,106
+89% +$591K 0.07% 187
2023
Q2
$682K Buy
5,731
+1,518
+36% +$157K 0.04% 290
2023
Q1
$391K Sell
4,213
-705
-14% -$61.8K 0.03% 346
2022
Q4
$402K Buy
+4,918
New +$374K 0.03% 272

Other funds holding ORCL

SageView Advisory Group's ORCL Position: Q2 2026 in Review

SageView Advisory Group increased its Oracle (ORCL) stake by 15% in Q2 2026, buying an estimated $381K and bringing the position to 16,533 shares worth $2.42M. The position accounts for 0.08% of the portfolio, ranked #139.

SageView Advisory Group first reported a position in ORCL in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.11M in Q3 2025. 3,528 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • SageView Advisory Group held 16,533 shares of Oracle worth $2.42M as of Q2 2026.
  • SageView Advisory Group bought 2,105 Oracle shares in Q2 2026, an estimated $381K.
  • Oracle made up 0.08% of SageView Advisory Group's portfolio in Q2 2026, its #139 holding.
  • SageView Advisory Group first reported a position in Oracle in Q4 2022 and has held it in 14 quarters since.
  • SageView Advisory Group's Oracle position peaked at $5.11M in Q3 2025.
  • 3,528 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.